keyword
https://read.qxmd.com/read/38655589/bacteriophages-as-a-potential-substitute-for-antibiotics-a-comprehensive-review
#21
REVIEW
Shruti O Kushwaha, Santosh Kumar Sahu, Virendra Kumar Yadav, Mayuri C Rathod, Dhaval Patel, Dipak Kumar Sahoo, Ashish Patel
Over the years, the administration of antibiotics for the purpose of addressing bacterial infections has become increasingly challenging due to the increased prevalence of antimicrobial resistance exhibited by various strains of bacteria. Multidrug-resistant (MDR) bacterial species are rising due to the unavailability of novel antibiotics, leading to higher mortality rates. With these conditions, there is a need for alternatives in which phage therapy has made promising results. Phage-derived endolysins, phage cocktails, and bioengineered phages are effective and have antimicrobial properties against MDR and extensively drug-resistant strains...
April 2024: Cell Biochemistry and Function
https://read.qxmd.com/read/38655418/split-doses-versus-whole-dose-bowel-preparation-using-polyethylene-glycol-for-colonoscopy-a-multicentric-prospective-lebanese-randomized-trial-between-2021-and-2023
#22
JOURNAL ARTICLE
Blaybel Sara, Hammoud Ghinwa, Mourda Layla, Hallal Mahmoud, Khalil Ali, Mckey Remy
BACKGROUND AND AIMS: Bowel preparation is considered as major obstacle before colonoscopy, and it is often reported as the most feared part of the procedure. The aim of this study is to determine the difference in efficacy between a split dose of PEG and the previous day regimen in cleaning the colon, using Boston bowel preparation scale. In addition, also to evaluate patient satisfaction regarding the modality of preparation. METHODS: The study included 200 hospitalized patients undergoing colonoscopy at Beirut hospitals between 2021 and 2023...
April 2024: Health Science Reports
https://read.qxmd.com/read/38655368/design-synthesis-biological-and-computational-screening-of-novel-pyridine-based-thiadiazole-derivatives-as-prospective-anti-inflammatory-agents
#23
JOURNAL ARTICLE
Naresh Podila, Naveen Kumar Penddinti, Mithun Rudrapal, Gourav Rakshit, Sathish Kumar Konidala, Veera Shakar Pulusu, Richie R Bhandare, Afzal B Shaik
In this study, a novel series of pyridine-based thiadiazole derivatives ( NTD1-NTD5 ) were synthesized as prospective anti-inflammatory agents by combining substituted carboxylic acid derivatives of 5-substituted-2-amino-1,3,4-thiadiazole with nicotinoyl isothiocyanate in the presence of acetone. The newly synthesized compounds were characterized by FTIR, 1 H NMR, 13 C NMR, and mass spectrometry. First, the compounds underwent rigorous in vivo testing for acute toxicity and anti-inflammatory activity and the results revealed that three compounds- NTD1 , NTD2 , and NTD3 , displayed no acute toxicity and significant anti-inflammatory activity, surpassing the efficacy of the standard drug, diclofenac...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38655322/engineering-5-flourouracil-and-leucovorin-loaded-vesicular-systems-for-possible-colon-specific-delivery-in-vitro-evaluation-and-real-time-cell-assay-against-hct-116-colon-cell-lines
#24
JOURNAL ARTICLE
Onyinyechi Lydia Ugorji, Ikechukwu Virgilius Onyishi, Amarauche Chukwu, Anthony Amaechi Attama
5-flourouracil (5-FU) is typically modulated with leucovorin (LEU) in clinical practice to improve clinical efficacy and patient survival rates. However, this combination has undesirable side effects and makes 5-FU more toxic. Hence, integrating a vesicular system (proniosomes) with another delivery vehicle may improve drug targeting, while resolving the aforementioned drawbacks. This study aimed to engineer 5-FU/LEU proniosomes for possible delivery to the colon. The modified slurry approach was used to create drug-loaded proniosomes (150 mg/9 g of carrier) using both water-soluble (dextrin (DEX) and lactose (LAC)) and insoluble (Neusilin FH2 (NEU)) carriers...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38655311/bibliometric-analysis-of-the-pirfenidone-and-nintedanib-in-interstitial-lung-diseases
#25
JOURNAL ARTICLE
Jia Liu, Faping Wang, Yiwen Hong, Fengming Luo
BACKGROUND: At the beginning of 21st century, reclassification of fibrosing interstitial lung diseases (ILD) scored academic concerning, and then propelled development. Decade before, pifenidone and nintedanib were approved for idiopathic pulmonary fibrosis, but no more drugs are yet available. To evaluate the development traits of pirfenidone and nintedanib in fibrosing ILD, including the influential country, institution, authors, keywords, and the major problems or the priorities of the field emerge and evolve, bibliometric analysis was used to summarize and draw scientific knowledge maps...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38655299/exploring-the-neuroprotection-of-the-combination-of-astragaloside-a-chlorogenic-acid-and-scutellarin-in-treating-chronic-cerebral-ischemia-via-network-analysis-and-experimental-validation
#26
JOURNAL ARTICLE
Fang Cheng, Jie Zhang, Pan Yang, Zufei Chen, Yinghao Fu, Jiajia Mi, Xingliang Xie, Sha Liu, Yanmei Sheng
Chronic cerebral ischemia (CCI) primarily causes cognitive dysfunction and other neurological impairments, yet there remains a lack of ideal therapeutic medications. The preparation combination of Astragalus membranaceus (Fisch.) Bunge and Erigeron breviscapus (Vant.) Hand.-Mazz have been utilized to ameliorate neurological dysfunction following cerebral ischemia, but material basis of its synergy remains unclear. The principal active ingredients and their optimal proportions in this combination have been identified through the oxygen and glucose deprivation (OGD) cell model, including astragaloside A, chlorogenic acid and scutellarin (ACS), and its efficacy in enhancing the survival of OGD PC12 cells surpasses that of the combination preparation...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38655186/safety-and-efficacy-of-east-asian-herbal-medicine-for-iron-deficiency-anemia-in-children-and-adolescents-a-systematic-review-and-meta-analysis
#27
Yoon Kyoung Jeong, Jae Hyun Kim, Sun Haeng Lee, Miran Bang, Gyu Tae Chang
BACKGROUND: This systematic review and meta-analysis aimed to evaluate the efficacy and safety of East Asian herbal medicine (HM) for iron deficiency anemia (IDA) in children and adolescents. METHODS: Twelve electronic databases were searched in 28 May 2023 for randomized controlled trials (RCTs) evaluating the efficacy of HM in children with IDA. The primary outcome measures for treatment included blood hemoglobin and serum ferritin levels, whereas the secondary outcomes included the total effective rate (TER), incidence of adverse events (AEs), average healing time, and hematologic indicators related to IDA...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38655036/evaluation-of-the-efficacy-of-silymarin-and-dexmedetomidine-on-kidney-and-lung-tissue-in-the-treatment-of-sepsis-in-rats-with-cecal-perforation
#28
JOURNAL ARTICLE
Aydin Yavuz, Ayşegül Küçük, Aydan İremnur Ergörün, Ali Doğan Dursun, Zeynep Yiğman, Metin Alkan, Mustafa Arslan
Sepsis is a systemic inflammatory response syndrome that develops in the host against microorganisms. This response develops away from the primary infection site and results in end-organ damage. The present study aimed to investigate the protective and therapeutic effects on lung and kidney tissue of silymarin (S) and dexmedetomidine (DEX) applied 1 h before and after sepsis induced by the cecal ligation and puncture (CLP) method in rats. A total of 62 rats was randomly divided into eight groups: i) Control (n=6); ii) cecal perforation (CLP; n=8); iii) S + CLP (n=8; S + CLP; S administered 1 h before CPL); iv) CLP + S (n=8; S administered 1 h after CLP); v) DEX + CLP (n=8; D + CLP; DEX administered 1 h before CLP); vi) CLP + D (n=8; DEX administered 1 h after CLP); vii) SD + CLP (n=8; S and DEX administered 1 h before CLP) and viii) CLP + SD (n=8; S and DEX administered 1 h after CLP)...
June 2024: Experimental and Therapeutic Medicine
https://read.qxmd.com/read/38654933/zwitterionic-polymer-dexamethasone-conjugates-penetrate-and-protect-cartilage-from-inflammation
#29
JOURNAL ARTICLE
Patrick Weber, Maryam Asadikorayem, František Surman, Marcy Zenobi-Wong
Improving the pharmacokinetics of intra-articularly injected therapeutics is a major challenge in treating joint disease. Small molecules and biologics are often cleared from the joint within hours, which greatly reduces their therapeutic efficacy. Furthermore, they are often injected at high doses, which can lead to local cytotoxicity and systemic side effects. In this study, we present modular polymer-drug conjugates of zwitterionic poly(carboxybetaine acrylamide) (pCBAA) and the anti-inflammatory glucocorticoid dexamethasone (DEX) to create cartilage-targeted carriers with slow-release kinetics...
June 2024: Materials today. Bio
https://read.qxmd.com/read/38654860/the-association-between-different-anesthetic-techniques-and-outcomes-in-patients-undergoing-transfemoral-aortic-valve-replacement
#30
JOURNAL ARTICLE
Ahmad Abuzaid, Ibrahim AbdelAal, Ahmed Galal
BACKGROUND: There is an increasing number of patients undergoing transfemoral aortic valve replacement (TAVR) with sedation. There is limited data assessing the efficacy and safety of the different types of sedative drugs. The objective was to compare two sedation techniques with regard to the need for vasoactive support, respiratory support, rate of conversion to general anesthesia (GA), common perioperative morbidities, intensive care unit (ICU) stay, and in-hospital mortality. METHODS: A retrospective chart review study conducted among patients who underwent TAVR at a specialized cardiac center between January 2016 and December 2019...
2024: Saudi Journal of Anaesthesia
https://read.qxmd.com/read/38654744/the-analysis-of-factors-affecting-medication-adherence-in-patients-with-myasthenia-gravis-a-cross-sectional-study
#31
JOURNAL ARTICLE
Yining Su, Xinxian Wang, Yuemeng Xing, Zhenni Wang, Hailing Bu, Xiaoyan Cui, Yunying Yang, Bingxing Cai
BACKGROUND: Clinically, patients with myasthenia gravis are generally treated with drugs to improve their physical condition, and poor medication adherence can hinder their recovery. Many studies have shown the importance of medication adherence for effective treatment. Various factors may affect a patient's medication adherence; however, studies concerning medication adherence in patients with myasthenia gravis are rare. OBJECTIVES: This study aimed to identify the factors related to medication adherence in patients with myasthenia gravis, and determine the possibility of predicting medication adherence...
2024: Therapeutic Advances in Neurological Disorders
https://read.qxmd.com/read/38654653/the-preclinical-discovery-and-clinical-evaluation-of-tirzepatide-for-the-treatment-of-type-2-diabetes
#32
REVIEW
Ioannis Avgerinos, Panagiota Kakotrichi, Thomas Karagiannis, Eleni Bekiari, Apostolos Tsapas
INTRODUCTION: Despite numerous antidiabetic medications available for the treatment of type 2 diabetes, a substantial percentage of patients fail to achieve optimal glycemic control. Furthermore, the escalating obesity pandemic underscores the urgent need for effective relevant pharmacotherapies. Tirzepatide, a novel dual GIP and GLP-1 receptor agonist, offers a promising therapeutic option. AREAS COVERED: This review describes the discovery and clinical development of tirzepatide...
May 2024: Expert Opinion on Drug Discovery
https://read.qxmd.com/read/38654553/the-trace-amine-associated-receptor-1-agonists-non-dopaminergic-antipsychotics-or-covert-modulators-of-d2-receptors
#33
JOURNAL ARTICLE
Gavin P Reynolds
A major effort of the pharmaceutical industry has been to identify and market drug treatments that are effective in ameliorating the symptoms of psychotic illness but without the limitations of the current treatments acting at dopamine D2 receptors. These limitations include the induction of a range of adverse effects, the inadequate treatment response of a substantial proportion of people with schizophrenia, and the generally poor response to negative and cognitive features of the disease. Recently introduced drug treatments have gone some way to avoiding the first of these, with a reduced propensity for weight gain, cardiovascular risk and extrapyramidal motor effects...
April 23, 2024: Journal of Psychopharmacology
https://read.qxmd.com/read/38654469/nirsevimab-expansion-of-respiratory-syncytial-virus-prevention-options-in-neonates-infants-and-at-risk-young-children
#34
REVIEW
J Hunter Fly, Lea S Eiland, Jeremy S Stultz
OBJECTIVE: Review available data from clinical trials of nirsevimab for efficacy and safety in the setting of respiratory syncytial virus (RSV) prophylaxis in infants and children, while exploring nirsevimab's role in clinical practice and highlighting continuing questions. DATA SOURCES: A literature search of PubMed was conducted utilizing the phrases "nirsevimab" and "medi8897." Additional references were identified through found references. Organizational guidelines, medication labeling, and regulatory organization presentations were utilized...
April 23, 2024: Annals of Pharmacotherapy
https://read.qxmd.com/read/38654302/emerging-therapeutic-frontiers-in-cancer-insights-into-posttranslational-modifications-of-pd-1-pd-l1-and-regulatory-pathways
#35
REVIEW
Rong Wang, Shiwei He, Jun Long, Yian Wang, Xianjie Jiang, Mingfen Chen, Jie Wang
The interaction between programmed cell death ligand 1 (PD-L1), which is expressed on the surface of tumor cells, and programmed cell death 1 (PD-1), which is expressed on T cells, impedes the effective activation of tumor antigen-specific T cells, resulting in the evasion of tumor cells from immune-mediated killing. Blocking the PD-1/PD-L1 signaling pathway has been shown to be effective in preventing tumor immune evasion. PD-1/PD-L1 blocking antibodies have garnered significant attention in recent years within the field of tumor treatments, given the aforementioned mechanism...
April 23, 2024: Experimental Hematology & Oncology
https://read.qxmd.com/read/38654290/identification-and-validation-of-a-novel-predictive-signature-based-on-hepatocyte-specific-genes-in-hepatocellular-carcinoma-by-integrated-analysis-of-single-cell-and-bulk-rna-sequencing
#36
JOURNAL ARTICLE
Yujian He, Wei Qi, Xiaoli Xie, Huiqing Jiang
BACKGROUND: Hepatocellular carcinoma represents a significant global burden in terms of cancer-related mortality, posing a substantial risk to human health. Despite the availability of various treatment modalities, the overall survival rates for patients with hepatocellular carcinoma remain suboptimal. The objective of this study was to explore the potential of novel biomarkers and to establish a novel predictive signature utilizing multiple transcriptome profiles. METHODS: The GSE115469 and CNP0000650 cohorts were utilized for single cell analysis and gene identification...
April 23, 2024: BMC Medical Genomics
https://read.qxmd.com/read/38654286/exploring-the-role-of-histone-deacetylase-and-histone-deacetylase-inhibitors-in-the-context-of-multiple-myeloma-mechanisms-therapeutic-implications-and-future-perspectives
#37
REVIEW
Jingjing Pu, Ting Liu, Xuzhen Wang, Amit Sharma, Ingo G H Schmidt-Wolf, Liping Jiang, Jian Hou
Histone deacetylase inhibitors (HDACis) are a significant category of pharmaceuticals that have developed in the past two decades to treat multiple myeloma. Four drugs in this category have received approval from the U.S. Food and Drug Administration (FDA) for use: Panobinonstat (though canceled by the FDA in 2022), Vorinostat, Belinostat and Romidepsin. The efficacy of this group of drugs is attributed to the disruption of many processes involved in tumor growth through the inhibition of histone deacetylase, and this mode of action leads to significant anti-multiple myeloma (MM) activity...
April 23, 2024: Experimental Hematology & Oncology
https://read.qxmd.com/read/38654209/optimizing-nicardipine-dosage-for-effective-control-of-pituitrin-induced-hypertension-in-laparoscopic-myomectomy-undergoing-total-intravenous-anesthesia
#38
JOURNAL ARTICLE
Chen Wang, Xiaoli Zhao, Yunyun Chen, Jianhua Xia, Xixue Zhang, Tingting Wang
BACKGROUND: This study aimed to determine the median effective dose (ED50) and 95% effective dose (ED95) of nicardipine for treating pituitrin-induced hypertension during laparoscopic myomectomy, providing guidance for the management of intraoperative blood pressure in such patients. METHODS: Among the initial 40 participants assessed, 24 underwent elective laparoscopic myomectomy. A sequential up-and-down method was employed to ascertain the ED50 of nicardipine based on its antihypertensive efficacy...
April 23, 2024: BMC Anesthesiology
https://read.qxmd.com/read/38654141/a-new-trop2-targeting-antibody-drug-conjugate-shows-potent-antitumor-efficacy-in-breast-and-lung-cancers
#39
JOURNAL ARTICLE
Dan-Dan Zhou, Xiao-Tian Zhai, Lan-Wen Zhang, Zi-Hui Xie, Ying Wang, Yong-Su Zhen, Rui-Juan Gao, Qing-Fang Miao
Trophoblast cell surface antigen 2 (Trop2) is considered to be an attractive therapeutic target in cancer treatments. We previously generated a new humanized anti-Trop2 antibody named hIMB1636, and designated it as an ideal targeting carrier for cancer therapy. Lidamycin (LDM) is a new antitumor antibiotic, containing an active enediyne chromophore (AE) and a noncovalently bound apoprotein (LDP). AE and LDP can be separated and reassembled, and the reassembled LDM possesses cytotoxicity similar to that of native LDM; this has made LDM attractive in the preparation of gene-engineering drugs...
April 23, 2024: NPJ Precision Oncology
https://read.qxmd.com/read/38654128/mesenchymal-stem-cells-as-therapeutic-vehicles-for-glioma
#40
REVIEW
Tomoya Oishi, Shinichiro Koizumi, Kazuhiko Kurozumi
Glioma is a disease with a poor prognosis despite the availability of multimodality treatments, and the development of novel therapies is urgently needed. Challenges in glioma treatment include the difficulty for drugs to cross the blood-brain barrier when administered systemically and poor drug diffusion when administered locally. Mesenchymal stem cells exhibit advantages for glioma therapy because of their ability to pass through the blood-brain barrier and migrate to tumor cells and their tolerance to the immune system...
April 23, 2024: Cancer Gene Therapy
keyword
keyword
60477
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.